MRK

BELZUTIFAN 40 MG

BELZUTIFAN 40 MG

WELIREG (BELZUTIFAN) 40 MG

VACCINES FOR ADULTS EO 14398

WELIREG (BELZUTIFAN) 40 MG

WINREVAIR 45MG/VIAL INJ,LYPHL

PATIENT MEDICATION OF BELZUTIFAN 40MG - ORDER PLACED FOR A PATIENT AT THE HUNTINGTON VA MEDICAL CENTER.

PHARMACY ORDER FOR VETERAN(S).

PHARMACEUTICAL ORDER FOR THE PUGET SOUND VA MEDICAL CENTER.

WELIREG 40 MG

S. 1339, Pharmacy Benefit Manager Reform Act S. 2076, Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act of 2021 Issues relating to, 340B program integrity; 340B of the Public Health Services Act; 340B issues; 340B drug pricing program; Drug pricing; Drug pricing and reimbursement issues; Cost and value of medicines; Vaccine issues; Package inserts and e-labeling; Package inserts, labeling issues, and e-labeling authorization legislation; Pharmaceutical supply channel issues; Drug shortages issues; Inflation Reduction Act (P.L. 117-169), issues relating to drug pricing provisions; One Big Beautiful Bill Act (P.L. 119-21), issues related to health care; FY-2027 Budget and Appropriations Legislation; Budget reconciliation drug pricing provisions; Commerce Justice, Science, and related agencies appropriations legislation for 2026; Interior, Environment, and related agencies appropriations legislation for 2026; Intellectual property protection and trade issues

Issues related to pharmacy benefit management reforms. Issues related to vaccine policy. Issues related to supply chain and domestic manufacturing capacity. Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing. Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes. Issues related to tariffs.

Drug pricing proposals. Pharmacy Benefit Manager reform proposals, clinical trial reforms, 340B. Vaccine safety and access issues, FDA reforms and changes, drug supply and shortage issues. Tax policy impacting health care and pharmaceutical industry; implementation of PL 119-21. Drug pricing proposals. Pharmacy Benefit Manager reform proposals. H.R. 1, "One Big Beautiful Bill Act" implementation and ORPHAN CURES Act, Implementation of IRA, and policy changes including the EPIC Act, Medicaid drug rebate program, Issues related to drug pricing in Medicare Parts B and D; Issues related to Most Favored Nation (MFN) drug pricing proposals. General pharmaceutical issues; Vaccine Injury Compensation Program (VICP); Pharmacy Benefit Manager (PBM) policy issues. Monitor Section 232 investigations, new trade agreements and tariffs, pharmaceutical IP.

Federal budget issues IRA, innovation, drug pricing in federal programs, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA IRA, Medicare and Medicaid payment and coverage issues

340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Food and Drug Administration issues. Drug Pricing. S.864: HELP Copays Act.

Issues related to vaccines; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC) Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to cyclic peptides; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to the implementation of the Inflation Reduction Act of 2022; Issues related to Senate Finance Dear Colleague process

Issues related to pharmaceutical IP, supply chain, and tariffs; Section 232 tariff investigation on branded pharmaceuticals. Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2027 National Defense Authorization Act), antimicrobial resistance, VICP Program, PBM reform, vaccine schedule and vaccine safety; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; CMMI Drug Pricing Demonstration Programs; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) imp

Issues related to chemical manufacturing. Issues related to domestic and international trade and tariff policies. Issues related to life sciences, laboratory and chemical manufacturing.

Education around access to vaccines. Public Law 119-21: One Big Beautiful Bill Act.